Bellerophon Therapeutics, Inc. (BLPH)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
16-Oct-23 8:51 PM
View: 
Puissance Capital Managemen...
10% Owner
Bellerophon Therapeutics, I... (BLPH) 13-Oct-23Sale 1,076,840$0.10$111,776.00(100%)
1.08M to 0
09-Jun-23 4:12 PM
View: 
Amin Naseem
Director
Bellerophon Therapeutics, I... (BLPH) 07-Jun-23Grant 47,578----19%
244.29K to 291.87K
07-Jun-23 9:21 PM
View: 
Puissance Life Science Oppo...
10% Owner
Bellerophon Therapeutics, I... (BLPH) 07-Jun-23Sale 134,421$0.83$111,569.00(11%)
1.21M to 1.08M
22-May-23 6:51 PM
View: 
Kim Bobae
VP Reg. Affairs & Quality
Bellerophon Therapeutics, I... (BLPH) 18-May-23Option Sale 1,288$10.00$12,880.00(12%)
11.18K to 9.89K
22-May-23 6:51 PM
View: 
Kim Bobae
VP Reg. Affairs & Quality
Bellerophon Therapeutics, I... (BLPH) 18-May-23Sale 8,167$10.00$81,670.00(83%)
9.89K to 1.72K
19-May-23 8:55 PM
View: 
Puissance Life Science Oppo...
10% Owner
Bellerophon Therapeutics, I... (BLPH) 18-May-23Private Sale 560,000$9.46$5,297,600.00(32%)
1.77M to 1.21M
22-May-23 6:51 PM
View: 
Kim Bobae
VP Reg. Affairs & Quality
Bellerophon Therapeutics, I... (BLPH) 18-May-23Option Exercise 1,288$7.47$9,620.1013%
9.89K to 11.18K
14-Feb-23 7:32 PM
View: 
Amin Naseem
Director
Bellerophon Therapeutics, I... (BLPH) 10-Feb-23Grant 84,000----52%
160.29K to 244.29K
13-Dec-22 5:25 PM
View: 
Shah Parag Suresh
VP of Business Operations
Bellerophon Therapeutics, I... (BLPH) 09-Dec-22Option Exercise 25,500----100%
0 to 25.5K
13-Dec-22 5:26 PM
View: 
Dekker Martin
VP OF ENGINEERING & MANUFACTUR
Bellerophon Therapeutics, I... (BLPH) 09-Dec-22Payment of Exercise 7,834$0.93$7,286.40(31%)
25.5K to 17.67K
13-Dec-22 5:25 PM
View: 
Fernandes Peter
PRINCIPAL EXECUTIVE OFFICER
Bellerophon Therapeutics, I... (BLPH) 09-Dec-22Option Exercise 32,500----100%
0 to 32.5K
13-Dec-22 5:25 PM
View: 
Laccona Nicholas
FINANCIAL OFFICER, (PFO & PAO)
Bellerophon Therapeutics, I... (BLPH) 09-Dec-22Payment of Exercise 5,530$0.93$5,143.45(31%)
18.0K to 12.47K
13-Dec-22 5:26 PM
View: 
Dekker Martin
VP OF ENGINEERING & MANUFACTUR
Bellerophon Therapeutics, I... (BLPH) 09-Dec-22Option Exercise 25,500----100%
0 to 25.5K
13-Dec-22 5:25 PM
View: 
Shah Parag Suresh
VP of Business Operations
Bellerophon Therapeutics, I... (BLPH) 09-Dec-22Payment of Exercise 7,834$0.93$7,286.40(31%)
25.5K to 17.67K
13-Dec-22 5:25 PM
View: 
Laccona Nicholas
FINANCIAL OFFICER, (PFO & PAO)
Bellerophon Therapeutics, I... (BLPH) 09-Dec-22Option Exercise 18,000----100%
0 to 18.0K
13-Dec-22 5:25 PM
View: 
Fernandes Peter
PRINCIPAL EXECUTIVE OFFICER
Bellerophon Therapeutics, I... (BLPH) 09-Dec-22Payment of Exercise 9,985$0.93$9,287.05(31%)
32.5K to 22.52K
04-Jan-22 4:10 PM
View: 
Amin Naseem
Director
Bellerophon Therapeutics, I... (BLPH) 31-Dec-21Grant 39,032----32%
121.25K to 160.29K
08-Jun-21 12:37 PM
View: 
Puissance Life Science Oppo...
10% Owner
Bellerophon Therapeutics, I... (BLPH) 07-Jun-21Grant 8,189$4.00$32,756.00< 1%
1.76M to 1.77M
26-Apr-21 12:39 PM
View: 
Puissance Life Science Oppo...
10% Owner
Bellerophon Therapeutics, I... (BLPH) 26-Apr-21Grant 609,231$4.00$2,436,920.0053%
1.15M to 1.76M
02-Apr-21 4:10 PM
View: 
Peacock Jonathan M
Director
Bellerophon Therapeutics, I... (BLPH) 31-Mar-21Grant 15,308----11%
141.72K to 157.03K
22-Mar-21 9:36 PM
View: 
New Mountain Investments Ii...
10% Owner
Bellerophon Therapeutics, I... (BLPH) 18-Mar-21Sale 400,000$5.48$2,192,000.00(40%)
1.01M to 609.23K
14-Sep-20 8:31 AM
View: 
Fares Wassim
Chief Medical Officer
Bellerophon Therapeutics, I... (BLPH) 10-Sep-20Market Purchase 4,000$10.18$40,708.00100%
0 to 4.0K
(23%)
09-Jun-20 4:01 PM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 08-Jun-20Market Purchase 2,600$12.87$33,454.204%
58.31K to 60.91K
(39%)
09-Jun-20 4:01 PM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 05-Jun-20Market Purchase 4,986$12.72$63,441.909%
53.33K to 58.31K
(38%)
22-May-20 7:25 AM
View: 
Puissance Life Science Oppo...
10% Owner
Bellerophon Therapeutics, I... (BLPH) 21-May-20Grant 1,153,850$13.00$15,000,000.00100%
0 to 1.15M
(40%)
20-Apr-20 10:47 AM
View: 
Puissance Cross-Border Oppo...
10% Owner
Bellerophon Therapeutics, I... (BLPH) 17-Apr-20Disposition (other) 553,250----(100%)
553.25K to 0
27-Jan-20 4:51 PM
View: 
Peacock Jonathan M
Director
Bellerophon Therapeutics, I... (BLPH) 23-Jan-20Grant 350,000----19%
1.88M to 2.23M
25-Nov-19 4:52 PM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 25-Nov-19Market Purchase 7,193$0.39$2,773.621%
585.73K to 592.92K
36%
25-Nov-19 4:52 PM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 22-Nov-19Market Purchase 1,050$0.37$393.54< 1%
584.68K to 585.73K
41%
25-Nov-19 4:52 PM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 21-Nov-19Market Purchase 200$0.37$74.00< 1%
584.48K to 584.68K
40%
19-Nov-19 4:35 PM
View: 
Dekker Martin
VP of Engineering & Manuf
Bellerophon Therapeutics, I... (BLPH) 15-Nov-19Payment of Exercise 27,134$0.34$9,225.56(18%)
151.75K to 124.62K
(55%)
19-Nov-19 4:36 PM
View: 
Fernandes Peter
Chief Regulatory & Safety Offr
Bellerophon Therapeutics, I... (BLPH) 15-Nov-19Payment of Exercise 40,280$0.34$13,695.20(18%)
222.3K to 182.02K
(55%)
19-Nov-19 4:36 PM
View: 
Shah Parag Suresh
VP of Business Operations
Bellerophon Therapeutics, I... (BLPH) 15-Nov-19Payment of Exercise 25,993$0.34$8,837.62(20%)
131.6K to 105.61K
(55%)
19-Nov-19 4:35 PM
View: 
Korner Assaf
CFO
Bellerophon Therapeutics, I... (BLPH) 15-Nov-19Payment of Exercise 32,987$0.34$11,215.60(33%)
99.06K to 66.08K
(55%)
19-Nov-19 4:36 PM
View: 
Tenenbaum Fabian
Chief Executive Officer
Director
Bellerophon Therapeutics, I... (BLPH) 15-Nov-19Payment of Exercise 76,823$0.34$26,119.80(16%)
484.28K to 407.46K
(55%)
28-Oct-19 5:15 PM
View: 
Venrock Associates Iv L P
10% Owner
Bellerophon Therapeutics, I... (BLPH) 28-Oct-19Market Sale 333,010$0.44$146,091.00(5%)
6.77M to 6.44M
(26%)
28-Oct-19 5:17 PM
View: 
Venrock Associates Iv L P
10% Owner
Bellerophon Therapeutics, I... (BLPH) 28-Oct-19Market Sale
Duplicate
333,010$0.44$146,091.00(5%)
6.77M to 6.44M
(26%)
28-Oct-19 5:15 PM
View: 
Venrock Associates Iv L P
10% Owner
Bellerophon Therapeutics, I... (BLPH) 25-Oct-19Market Sale 56,242$0.45$25,511.40(< 1%)
6.82M to 6.77M
(22%)
28-Oct-19 5:17 PM
View: 
Venrock Associates Iv L P
10% Owner
Bellerophon Therapeutics, I... (BLPH) 25-Oct-19Market Sale
Duplicate
56,242$0.45$25,511.40(< 1%)
6.82M to 6.77M
(22%)
28-Oct-19 5:15 PM
View: 
Venrock Associates Iv L P
10% Owner
Bellerophon Therapeutics, I... (BLPH) 24-Oct-19Market Sale 704,595$0.50$353,354.00(9%)
7.53M to 6.82M
(9%)
28-Oct-19 5:17 PM
View: 
Venrock Associates Iv L P
10% Owner
Bellerophon Therapeutics, I... (BLPH) 24-Oct-19Market Sale
Duplicate
704,595$0.50$353,354.00(9%)
7.53M to 6.82M
(9%)
14-Jun-19 11:46 AM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 12-Jun-19Market Purchase 50,000$0.64$31,905.009%
534.48K to 584.48K
(13%)
24-May-19 9:30 AM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 22-May-19Market Purchase 27,500$0.60$16,533.005%
506.98K to 534.48K
(7%)
23-May-19 4:46 PM
View: 
Edmonds Amy
VP Clinical Operations & Admin
Bellerophon Therapeutics, I... (BLPH) 22-May-19Payment of Exercise 35,827$0.61$21,797.10(20%)
176.04K to 140.22K
8%
22-May-19 11:14 AM
View: 
Peacock Jonathan M
Director
Bellerophon Therapeutics, I... (BLPH) 21-May-19Market Purchase 20,000$0.61$12,198.001%
1.86M to 1.88M
(8%)
22-May-19 11:14 AM
View: 
Tenenbaum Fabian
Chief Executive Officer
Director
Bellerophon Therapeutics, I... (BLPH) 21-May-19Market Purchase 5,000$0.60$2,975.001%
479.28K to 484.28K
(6%)
22-May-19 11:15 AM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 21-May-19Market Purchase 43,280$0.61$26,370.509%
463.7K to 506.98K
(8%)
25-Jan-19 4:22 PM
View: 
Wang Theodore T
Director
10% Owner
Bellerophon Therapeutics, I... (BLPH) 25-Jan-19Market Purchase 450,000$0.70$315,000.003285%
13.7K to 463.7K
(20%)
25-Jan-19 4:12 PM
View: 
Amin Naseem
Director
Bellerophon Therapeutics, I... (BLPH) 25-Jan-19Market Purchase 571,429$0.70$400,000.0046%
1.25M to 1.82M
(20%)
25-Jan-19 4:21 PM
View: 
Peacock Jonathan M
Director
Bellerophon Therapeutics, I... (BLPH) 25-Jan-19Market Purchase 714,286$0.70$500,000.0063%
1.14M to 1.86M
(20%)